A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia

NCT00947531 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

242

Enrollment

INDUSTRY

Sponsor class

Conditions

Vascular Dementia

Interventions

DRUG: Cerebrolysin
DRUG: 0.9% Saline Solution

Sponsor

Ever Neuro Pharma GmbH

Collaborators

[object Object]
[object Object]